NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Wednesday that its third quarter revenues rose 54 percent driven by increased SmartChip capital equipment sales.

For the three months ended Sept. 30, WaferGen reported total revenues of $2 million compared to $1.3 million in Q3 2014, in line with analysts' consensus estimate.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.